INS and type 1 diabetes mellitus: Many people treated with insulin fail to reach their glycemic targets, which is known to increase the risk of microvascular and macrovascular complications, resulting in substantial morbidity and mortality.13,14,24 Our findings in this observational study in adults with T1D using CGM highlight the potential benefits on glycemic control and injection behavior when connected pen data contribute to insulin treatment.